1. Home
  2. LSF vs PDSB Comparison

LSF vs PDSB Comparison

Compare LSF & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laird Superfood Inc.

LSF

Laird Superfood Inc.

N/A

Current Price

$2.90

Market Cap

42.3M

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

N/A

Current Price

$1.34

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSF
PDSB
Founded
2015
2005
Country
United States
United States
Employees
N/A
10
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.3M
42.4M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
LSF
PDSB
Price
$2.90
$1.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
★ $7.17
$4.75
AVG Volume (30 Days)
21.3K
★ 32.0M
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 75.28
28.16
EPS
★ N/A
N/A
Revenue
★ $49,889,286.00
N/A
Revenue This Year
$188.00
N/A
Revenue Next Year
$32.35
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.23
N/A
52 Week Low
$1.96
$0.20
52 Week High
$5.59
$1.55

Technical Indicators

Market Signals
Indicator
LSF
PDSB
Relative Strength Index (RSI) 26.32 76.55
Support Level $2.40 $0.60
Resistance Level $3.59 $1.55
Average True Range (ATR) 0.24 0.15
MACD -0.04 0.04
Stochastic Oscillator 1.72 96.30

Price Performance

Historical Comparison
LSF
PDSB

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the development and marketing of food and beverage products focused on health and wellness. The company's product portfolio includes coffee creamers, coffee, tea, hot chocolate, hydration and beverage enhancement products, and snacks, made using natural and functional ingredients.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: